In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MacroChem Corp.

Division of Abeona Therapeutics Inc.
www.macrochem.com

Latest From MacroChem Corp.

Access to acquire MacroChem

Access Pharmaceuticals, which is focused on developing and commercialising cancer products, is to acquire fellow US firm MacroChem in a deal valued at around $9 million. MacroChem's portfolio includes two early clinical-stage oncology products that it acquired when it bought Virium Pharmaceuticals earlier this year.

Gastrointestinal Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abeona Therapeutics Inc.
  • Senior Management
  • Robert J DeLuccia, Pres. & CEO
    Bernard R Patriacca, VP, CFO
    David P Luci, VP, Corp. Dev.
  • Contact Info
  • MacroChem Corp.
    Phone: (781) 489-7310
    40 Washington St., Ste. 220
    Wellesley Hills, MA 02481
    USA
UsernamePublicRestriction

Register